Hikma at a glance
Discover what drives us
Latest news
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
22 February 2024
- Hikma confirms 2025 guidance and updates medium-term growth outlook Press Release, Financial Results 06 November 2025 Hikma confirms 2025 guidance and updates medium-term growth outlook
- Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection Press Release, Product 06 November 2025 Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
- Hikma R&D. Innovating analytical development. Meet Edvin Brusač Story, Life at Hikma 23 October 2025 Hikma R&D. Innovating analytical development. Meet Edvin Brusač
- Hikma R&D. Innovating formulation development. Meet Anas Abdull-kareem Younues Story, Life at Hikma 15 October 2025 Hikma R&D. Innovating formulation development. Meet Anas Abdull-kareem Younues